PHILIP LOCICERO: Open Payments
NPI 1255097036 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $691 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $189 |
| Alnylam Pharmaceuticals Inc. | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| PFIZER INC. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: Wegovy, ONPATTRO, JARDIANCE, AIRSUPRA, VOQUEZNA, ELIQUIS, LEQVIO, Kerendia.
Industry payments across MA — which companies pay providers there.
